Zacks Bull and Bear of the Day Highlights: Alexion Pharmaceuticals, CSN, CBS, News Corporation and Comcast - Press Releases

For Immediate Release

Chicago, IL - April 19, 2012 - Zacks Equity Research highlights: Alexion Pharmaceuticals ( ALXN ) as the Bull of the Day and CSN ( SID ) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on CBS Corporation ( CBS ), News Corporation ( NWSA ) and Comcast Corporation ( CMCSA ).

Full analysis of all these stocks is available at .

Here is a synopsis of all five stocks:

Bull of the Day :

We are upgrading Alexion Pharmaceuticals ( ALXN ) to Outperform from Neutral on valuation grounds; we believe that there is significant upside scope from current levels. Alexion performed very well in the final quarter of 2011, beating the Zacks Consensus Estimate by $0.07 thanks to strong Soliris sales.

We are also impressed by the label expansion of Soliris in the US and EU for the aHUS indication, which has boosted the sales potential of the drug. We expect Soliris to continue performing well in 2012.

Consequently, we have increased our revenue estimate for 2012 and expect Soliris sales to exceed $1 billion in 2012. Management, too, gave a bright outlook for 2012. Our long-term recommendation is in line with the Zacks #1 Rank (Strong Buy rating) carried by the stock in the short run. Our target price is $106.00.

Bear of the Day :

Brazilian steel company Companhia Siderurgica Nacional or CSN ( SID ) posted satisfactory fourth quarter results with EPADR of roughly 31 cents per share, much above the Zacks Consensus Estimate of 20 cents per share. Despite a few positives, there are a few irrefutable downsides pertaining to the stock of the company at present.

These downsides include rising costs of goods sold, presence of serious competition and foreign market fluctuations, which are adversely affecting sales of the company in the clouded fiscal scenario. Earnings estimates for 2012 have decreased on a year over year basis.

Thus, we are downgrading shares to an Underperform recommendation from a previous sideline view on the stock at present. Our target price on the stock is $8.50, based on a 2012 P/E multiple of 8.6x.

Latest Posts on the Zacks Analyst Blog :

3 Tech Titans Report Earnings

CBS Expands in Gaming & eSports

CBS Corporation ( CBS ) is always eager to add diverse revenue streams to hedge against economic cycles. One such move is the company's expansion into the fastest growing live gaming and eSports market.

The company through one of its divisions, CBS Interactive, has entered into a partnership with TwitchTV, a leading video game broadcasting network and Major League Gaming ( MLG ), the world's most renowned eSports league.

CBS remains well positioned to boost revenues in the coming quarters through its strategic initiatives and operating efficiencies. Management remains optimistic and expects growth momentum to continue in fiscal 2012 based on strong political advertising, reverse compensation from affiliates, strong demand of its content and streaming and retransmission consent.

Moreover, CBS is likely to benefit from an increase in political ad spending as it owns more TV stations than its competitors News Corporation 's ( NWSA ) Fox and Comcast Corporation 's ( CMCSA ) NBC.

The company expects strong political TV advertising revenues in the current fiscal year, which in turn, is anticipated to enhance its profitability. According to the company's Chief Executive Officer Les Moonves, profits are expected to rise by $180 million primarily due to political ads, which surpassed the profits of the presidential election last year.

We believe that CBS Corporation's long-term agreements with the NFL, the NCAA, the SEC and the Grammys will generate stream of positive cash flows for the company in the long run.

Currently, we have a long-term Outperform rating on the stock. Moreover, CBS Corp. holds a Zacks # 1 Rank, which translates into a short-term Strong Buy rating.

Get the full analysis of all these stocks by going to .

About the Bull and Bear of the Day

Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.

About the Analyst Blog

Updated throughout every trading day, the Analyst Blog provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous analyst coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting .

About Zacks is a property of Zacks Investment Research , Inc., which was formed in 1978 by Leonard Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank , which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment

Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at .

Visit for information about the performance numbers displayed in this press release.

Follow us on Twitter:

Join us on Facebook:

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

ALEXION PHARMA ( ALXN ): Free Stock Analysis Report

CBS CORP ( CBS ): Free Stock Analysis Report

COMCAST CORP A ( CMCSA ): Free Stock Analysis Report

NEWS CORP INC-A ( NWSA ): Free Stock Analysis Report

CIA SIDERUR-ADR (SID): Free Stock Analysis Report

To read this article on click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos


    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

    Learn More